News & Views
Biotech Pioneer Appointed to Growing UK Life Science Company
Jan 31 2008
With a career spanning more than three decades as a senior researcher and manager in the pharmaceutical sector Ken Powell is widely acknowledged by the industry as one of its pioneers. His previous positions include CEO of Arrow Therapeutics, Head of Antiviral Research and Head of Biology at the Wellcome Foundation and Professor of Virology and Cell Biology at the Wolfson Institute for Biomedical Research at University College, London.
Ken Powell has an enviable record in founding and building life science start-ups. During his period of employment with the Wolfson Institute he helped establish Inpharmatica, now part of Galapagos NV and Ark Therapeutics which listed on the London Stock Exchangeâs main market in March 2004. Ken currently serves as the Head of Arrow Therapeutics, which he founded in 1998 and was acquired by Astra-Zeneca PLC for $150 million in February 2007.
Commenting on his appointment Ken Powell said âI have accepted the role of Executive Chairman of Q Chip for the simple reason I am excited by its prospects. It has undertaken some very exciting research, which provides the foundations for a strong pipeline of applications and products. The product opportunities presented by Q Chipâs technology will offer cost effective solutions to some of the most pressing issues in the biotech industry. I am particularly delighted to have the opportunity to assist Q Chip in the development of its MicroPlantTM drug delivery technology and expanding the commercial reach of its unique ReaX⢠range of easy to use, beaded molecular reagents.â
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark